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ABSTRACT  26 
Objective: Patellofemoral pain (PFP) is common among young individuals. Female 27 
adolescents with PFP present typically with localised mechanical hyperalgesia 28 
around the knee but the effect of central pain mechanisms are unknown. This study 29 
aimed to compare temporal summation of pain, conditioned pain modulation (CPM), 30 
and widespread hyperalgesia in young female adults with PFP and age-matched 31 
pain-free controls.  32 
Design: Cross-sectional study.  33 
Setting and subjects: Twenty young female adults (19 - 21 years) with long-34 
standing PFP were compared with 20 pain-free controls from the same population-35 
based cohort 36 
Methods: Cuff algometry was used to assess the pain detection threshold. Temporal 37 
summation of pain was assessed by recording the pain intensity on a visual 38 
analogue scale during repeated cuff pressure stimulations at pain tolerance intensity 39 
on the lower leg. CPM was recorded as the increase in cuff pain detection threshold 40 
in response to experimental conditioning pain imposed on the contralateral arm. 41 
Handheld pressure algometry was used to assess pressure pain thresholds (PPT) 42 
on the knee, shin, and forearm. The examiner was blinded to the type of subject 43 
assessed.  44 
Results: Compared with pain-free controls, young females with PFP did not show a 45 
decrease in cuff pain thresholds (P<0.40) or facilitated temporal summation (P<0.15), 46 
but had a lower CPM response (P<0.04) and lower PPTs (P<0.005). 47 
Conclusions: Young female adults with long-standing PFP demonstrated impaired 48 
CPM. This is important as PFP, a peripheral pathology, might have important central 49 
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components which need to be studied in order to understand its extent and 50 
therapeutic implications. 51 
Key words: patellofemoral pain; central sensitization; CPM; hyperalgesia; 52 
experimental pain 53 
54 
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INTRODUCTION 55 
Patellofemoral pain (PFP) is a common knee condition among individuals who 56 
participate in repetitive knee loading activities (1, 2). The prevalence of PFP is 57 
more than twice as high among females compared to males and data from 58 
sports medicine clinics suggest that PFP is the most common knee condition 59 
and may account for 25% of all consultations regarding knee pain (3, 4). PFP 60 
is defined as pain anteriorly around the patella with pain that increases during 61 
prolonged sitting, squatting, kneeling, and stair climbing (5). Prospective 62 
studies have highlighted a poor long-term prognosis with only 1/3 being pain 63 
free 12 months after initiation of treatment (6).  64 
Mechanical hyperalgesia was recently demonstrated by reduced pressure pain 65 
thresholds (PPTs) assessed around the knee and on the tibialis anterior muscle in 66 
female adolescents with PFP compared with pain free controls (7). The distal 67 
hyperalgesia observed at the tibialis anterior muscle may reflect segmental 68 
spreading of hyperalgesia (8). In some chronic musculoskeletal pain conditions with 69 
widespread hyperalgesia such as osteoarthritis (OA) and fibromyalgia, temporal 70 
summation of the pain perception to repetitive pressure pain stimulations appears to 71 
be facilitated compared with pain free controls, which is thought to be the result of 72 
facilitated central mechanisms (9, 10). Furthermore, studies have demonstrated 73 
reduced sensory perception to thermal stimulation and vibration (11, 12), indicating 74 
altered sensory function in patients with PFP. 75 
 76 
Painful stimulation evokes a multisegmental hypoalgesia often referred to as 77 
conditioned pain modulation (CPM); a manifestation of the descending modulatory 78 
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effects characterised by attenuated pain response to a painful test stimulus when 79 
another painful conditioning stimulus is applied (13). CPM is a proxy of the 80 
effectiveness of the endogenous analgesia system. Previous studies have shown 81 
impaired CPM in both knee and hip OA (9, 10, 14) as well as other non-arthritic 82 
chronic pain conditions (15, 16). Impaired CPM is clinically important as it may be 83 
associated with a higher risk of developing chronic post-operative pain (17). 84 
Collectively, identification of sensitised central mechanisms and widespread 85 
hyperalgesia appears to be clinically important and may be associated with higher 86 
risk of long-standing pain (17-21). However, it has never been investigated among 87 
young female adults with PFP.  88 
 89 
The aims of this study were to assess 1) temporal summation of cuff-induced 90 
pressure pain, 2) CPM assessed by cuff-algometry, and 3) widespread mechanical 91 
hyperalgesia in young female adults with PFP compared with age matched healthy 92 
pain-free controls. It was hypothesised that young adults with PFP would have 93 
increased temporal summation of pain and impaired CPM compared with pain-free 94 
controls and that PPTs around the knee and at sites remote from the area of self-95 
reported knee pain would be lower among young female adults with PFP compared 96 









The design was a cross-sectional study nested within a population-based cohort. 104 
Young female adults diagnosed with PFP were matched to a gender- and age-105 
matched comparison group of pain-free controls. Both young adults with PFP and 106 
pain-free controls were recruited from the same population-based cohort (the 107 
Adolescent Pain in Aalborg 2011) (22). This cohort has been followed since 2011 108 
and consisted of 2200 adolescents between 15 and 19 years of age. From these, 109 
153 were diagnosed with PFP using previously described inclusion and exclusion 110 
criteria (23, 24). In short, the patients with PFP were required to have an insidious 111 
onset of anterior knee or retropatellar pain of more than 6 weeks duration and 112 
provoked by at least two of the following daily activities: prolonged sitting or kneeling, 113 
squatting, running, hopping, or stair walking; tenderness on palpation of the patella, 114 
pain when stepping down or double leg squatting; and worst pain during the previous 115 
week of more than 3 cm on a 10 cm visual analogue scale (VAS). Exclusion criteria 116 
were concomitant injury or pain from the hip, lumbar spine, or other knee structures; 117 
previous knee surgery; self-reported patellofemoral instability; knee joint effusion. 118 
From the 153 adolescents with PFP, 121 were enrolled in a randomised trial (24). 119 
Participants who were previously diagnosed with PFP in the original trial (23) were 120 
included in a telephone interview to inquire if they still had knee pain and if so they 121 
were invited to participate in the current study. Pain-free controls were randomly 122 
recruited from the same population-based cohort by telephoning a random sample 123 
with approximately the same age, gender, and sports participation as the PFP group. 124 
The inclusion criteria for pain-free controls were: No current self-reported 125 
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musculoskeletal pain; no self-reported prior surgery in the lower extremity; no self-126 
reported neurological or other medical conditions. The study was conducted in 127 
accordance with the Helsinki Declaration and was approved by the local ethics 128 
committee in the North Denmark Region (N-20110020).  129 
 130 
Protocol 131 
All parameters were collected by an examiner who was blinded towards group 132 
allocation (PFP vs. pain-free controls). Data was collected from the side of the most 133 
painful knee among those with PFP and the same side matched on dominance on 134 
pain-free controls. Manual pressure algometry, cuff pressure algometry, temporal 135 
summation of pain, and CPM were assessed in a sequence on a single day with 136 
approximately 3-5 minutes between each test. The reliability of manual PPT 137 
measurements performed on pain-free young adults has previously been 138 
investigated and found to be acceptable for sites around the hand and head 139 
(intraclass correlation coefficients (ICC) ranging from 0.69 to 0.88) (25) In pain-free 140 
adults, the reliability of computer controlled cuff-algometry for assessing pressure 141 
algometry, temporal summation of pain, and CPM has been found to be good to 142 
excellent with ICCs ranging from 0.60-0.89 (26). The primary outcome was temporal 143 
summation of pain measured as the change in VAS during repeated cuff stimulations 144 
on the lower leg. Secondary outcomes included 1) cuff pressure pain sensitivity 145 
recorded on the lower leg, 2) CPM with the outcome being the change in cuff pain 146 
sensitivity on the lower leg after cuff-induced arm pain (the conditioning stimulus), 147 
and 3) PPTs at the patella, the tibialis anterior muscle, and the lateral epicondyle. 148 
 149 
Pressure algometry 150 
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PPTs were assessed using a hand-held pressure algometer (Somedic Sales AB, 151 
Sweden) with a stimulation area of 1 cm2 placed perpendicular to the skin. Pressure 152 
was applied at a rate of 30 kPa/s which was verified using the inbuilt digital indicator 153 
on the algometer. The individuals were instructed to indicate when the sensation 154 
changed from a sensation of pressure to the first sensation of pain. Measurements 155 
were done with the individuals resting in a reclining position and the knee slightly 156 
flexed at 15 degrees. PPT was measured at sites close to the knee to reflect 157 
localised hyperalgesia and on the contralateral site distant to the knee to investigate 158 
widespread hyperalgesia (8-10). The PPTs were measured twice at each site and 159 
the average was calculated and used for the analyses. Three assessment sites were 160 
located on: 1) The knee at the centre of the patella. 2) The muscle belly of the tibialis 161 
anterior muscle 5 cm distal to the tibial tuberosity. 3) The elbow, on the lateral 162 
epicondyle of the humerus.  163 
 164 
Computer-controlled cuff pressure algometry 165 
Cuff pressure pain detection thresholds (PDT) and cuff pressure pain tolerance 166 
(PTT) were assessed by a computer-controlled cuff pressure algometer (Nocitech, 167 
Denmark and Aalborg University, Denmark). Computer controlled cuff algometry 168 
have previously been widely used to study central pain mechanisms (9, 10, 27, 28) 169 
and has the advantage of being user independent. A 13-cm wide silicone tourniquet 170 
cuff (VBM, Germany) with an equal-sized proximal and distal chamber was wrapped 171 
around the lower leg on the side with the worst knee pain. The cuff was mounted 172 
with a 5 cm distance between its upper rim and the tibial tuberosity. The cuff 173 
pressure was increased with a rate of 1 kPa/s simultaneously in both chambers and 174 
the maximal pressure limit of the system was 100 kPa which may cause some 175 
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participants to reach 100 kPa before reaching PTT. The participants used an 176 
electronic VAS to rate their pressure-induced pain intensity and a button to release 177 
the pressure. The electronic VAS was sampled at 10 Hz. Zero and ten cm extremes 178 
on the VAS were defined as “no pain” and “maximal pain”, respectively. The 179 
participants were instructed to rate the pain intensity continuously on the electronic 180 
VAS from the first sensation of pain and to press the pressure release button when 181 
the pain was intolerable. The pressure value when the subject rated the sensation of 182 
pain as 1 cm on the VAS was defined as the PDT and the pressure recorded when 183 
the subject terminated the cuff inflation was defined as the PTT.  184 
 185 
Temporal summation of cuff-induced pressure pain  186 
Temporal summation was assessed by the computer-controlled cuff algometer 187 
(Nocitech, Denmark). Ten cuff pressure stimuli (1-s duration and 2-s interstimulus 188 
interval) were delivered to the lower leg by simultaneous inflation of both cuff 189 
chambers at an intensity equivalent to PTT recorded during the assessment of the 190 
cuff pain sensitivity. In the period between stimuli, a constant non-painful pressure of 191 
5 kPa was kept, thus ensuring that the cuff did not move. The participants were 192 
instructed to rate the pain intensity continuously on the electronic VAS. The mean 193 
VAS score during the 1-s interval between stimulations after each of the 10 stimuli 194 
was extracted and then normalised by subtraction of the mean VAS scores from the 195 
first stimulation.  196 
 197 
Conditioned pain modulation  198 
Experimental tonic pain was induced in the contralateral arm by cuff-induced pain 199 
(conditioning stimulation), and assessment of cuff PDT and PTT was performed on 200 
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the lower leg before and during the conditioning stimulus on the arm. A 7.5-cm-wide 201 
tourniquet cuff (VBM, Germany) was wrapped around the left arm with the lower rim 202 
of the cuff placed 3 cm proximal to the cubital fossa. The computer-controlled cuff 203 
algometer maintained a constant pressure at 60 kPa. The CPM effect was 204 
expressed as the percentages increase of PDT and PTT, respectively, from baseline 205 
to the conditioning assessments. If subjects reached 100 kPa as PTT before 206 
conditioning cuff-pain these were excluded from further analysis. A-priori it was 207 
expected that some subjects would reach 100 kPa and therefore the CPM effect 208 
using PTT was only included as an explorative outcome. 209 
 210 
Self-reported outcomes 211 
The following clinical self-reported measures were used: 1) Patellofemoral 212 
Osteoarthritis Outcome Score (KOOS)(29), worst pain intensity during the last four 213 
weeks, and current pain measured on a 0-10 numeric rating scale (NSR), 2) 214 
symptom duration (months), 3) most painful knee (right/left), 4) uni- or bilateral pain 215 
(yes/no), and pain localisation measured using the Navigate pain app (30). 216 
 217 
Statistical analysis  218 
The sample-size was based on the primary outcome of detecting a difference in 219 
normalized VAS during temporal summation from stimuli 1 to stimuli 10 of 1.5 cm(10). 220 
Common standard deviation was estimated to be 1.5 cm and with a power 0.80 and 221 
alpha at 0.05 this corresponds to a sample-size of minimum 16 in each group. 222 
 223 
All analyses were defined a-priori. The primary analysis was a comparison between 224 
groups in the change in VAS during temporal summation. Secondary analyses 225 
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included comparisons of cuff PDT, cuff PTT, CPM, and PPTs at the centre of the 226 
patella, m. tibialis anterior and the lateral epicondyle. Unpaired t-tests were used for 227 
all comparisons except for the PPTs where a two-way ANOVA was used with group 228 
and site as factors. All calculations were performed using Stata version 11 229 
(StataCorp, College Station, Texas, USA). Mean values and 95% confidence 230 
intervals (CI) are reported if data were normally distributed and otherwise they are 231 
presented as median and interquartile range (IQR). P-values less than 0.05 were 232 
considered significant. 233 
234 
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RESULTS 235 
The female adults with PFP had a median symptom duration of 6 years and reported 236 
in general intermittent episodes (Table 1) of peri-patellar pain (Figure 1).  237 
Table 1: Demographics and patient reported outcomes  238 
 
 
Pain free (n=20) 
 
Patellofemoral pain (n=20) P-values 
Age [years]* 20.5 (20.0-21.0) 20.0 (19.0-21.0) 0.26 
Weight [kg] 61.7 (7.4) 63.8 (8.3) 0.40 
Height [cm] 169 (5) 170 (5) 0.53 
Sports participation (% yes) 75% 80% 0.61 
Duration of symptoms (years)* N/A 6 (4.5-7) - 
Worst pain last four weeks [NRS] 0 (0-0) 7 (5.5-8.0) <0.0001 
KOOS symptoms 96 (5) 79 (11) <0.0001 
KOOS pain 99 (2) 74 (11) <0.0001 
KOOS activity 100 (1) 84 (10) <0.0001 
KOOS Sport 98 (3) 59 (23) <0.0001 
KOOS QoL 97 (7) 55 (18) <0.0001 
PainDetect* 0 (0-0) 7.5 (4.5-11.0) <0.0001 
Self-reported description of pain from 
PainDetect 
   
   Persistent pain with slight fluctuations (n)   4  
   Persistent pain with pain attacks (n)   3  
   Pain attacks without pain between them (n)   12  
   Pain attacks with pain between them (n)  1  
* Median and interquartile range. 0 to 100, best to worst scale. PFOOS: Patellofemoral Osteoarthritis 
Outcome Score  
 239 
 240 
Figure 1: The 20 small figures show the participants usual self-reported pain, while the large picture 241 
show the average pain location of the 20 young adults with patellofemoral pain. 242 
 243 
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Temporal summation of pain 244 
The VAS scores following the ten repeated cuff stimulations showed a progressive 245 
increase in both groups illustrating the temporal summation of pain.   246 
The analysis showed no signification difference between groups in the increase in 247 
VAS from stimulus 1 to 10 (0.9 cm (95%CI: -0.5; 2.3 cm, t(38)=1.48, P=0.15) (Figure 248 
2). 249 
 250 
Figure 2: Mean (+1.96*SE, N=20) of the visual analogue scale (VAS) scores after 10 cuff pressure 251 
pain stimulations at the pain tolerance intensity in females with patellofemoral pain (open symbols) 252 
and pain free controls (solid symbols). 253 
 254 
Cuff pain sensitivity 255 
There were no significant differences in PDT (-5 kPa (95%CI: -18; 7 kPa, t(38)=0.85, 256 
P=0.40)) or PTT (-8 kPa (95%CI: -21; 6, t(38)=1.11, P=0.27) between young female 257 
adults with PFP and pain-free controls (Figure 3). 258 
 259 
 260 
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Figure 3: Mean ((+ 1.96*SE, N=20) cuff pain detection threshold (PDT) and pain tolerance (PTT) 261 




Conditioning pain modulation 266 
Young female adults with PFP had a 78% (95%CI: 4; 151%, t(38)=2.15, P<0.04) 267 
lower CPM response in their PDT (Figure 4). The explorative CPM assessments 268 
based on PTT measurements excluded 11 pain-free controls who reached 100 kPa 269 
before experimental cuff-pain tolerance was reached but showed a 20% lower PTT 270 
response among young female adults with PFP compared to pain-free controls 271 
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Figure 4: Percentage increase (+1.96*SE, N=20) in pain detection threshold (PDT) and pain tolerance 276 
(PTT) from before, to during (CPM) the experimental tonic pain was induced in the contralateral arm 277 
in female with patellofemoral pain (open symbols) and pain-free controls (solid symbols). The PDT 278 
includes 18 individuals in each group as the measurement system malfunctioned during collection of 279 
data. * denotes significant differences (P<0.04). 280 
 281 
 282 
Pressure pain sensitivity 283 
There was a significant effect of group (PFP vs. pain-free controls) on PPTs (F1, 114 = 284 
8.2, P < 0.005) (-68 kPa, (95%CI: -115; -21 kPa)) and PPT site (F2, 114 = 7.1, P < 285 
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Figure 5: Mean (+1.96*SE, N=20) handheld pressure pain threshold (PPT) on the center of the 292 
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Discussion 298 
Young female adults with long-standing PFP were characterised by impaired CPM 299 
assessed by PDT and spreading hyperalgesia, but contrary to our main hypothesis, 300 
they showed no signs of facilitated temporal pain summation. This is the first study to 301 
provide evidence for an altered pain processing among young adults with PFP.  302 
 303 
Temporal summation of pain 304 
Contrary to the a priori hypothesis, young female adults with long-lasting chronic 305 
PFP did not have facilitated temporal summation. Previous studies have shown a 306 
facilitated temporal summation of pain in patients with knee OA and in other 307 
musculoskeletal pain disorders such as fibromyalgia, chronic low back pain and 308 
whiplash (31-34). The difference in results may potentially be explained by the 309 
difference in study populations. The current study population reported knee pain for 310 
an average of six years, which is similar to previous studies on knee OA (10), but 311 
they are indeed much younger (≈45 years younger). The young adults with PFP 312 
developed knee pain while they were in their early teens while patients with knee OA 313 
developed knee pain in their mid-50s. Likewise the young adults with PFP presented 314 
slightly lower peak pain intensities compared to sensitised adult patients with knee 315 
OA typically reporting peak pain during the last 24 hours of 8 on a NRS (10). This is 316 
important because higher peak pain is associated with a more facilitated temporal 317 
summation (10). The pain reported by young adults with PFP is normally associated 318 
with patellofemoral joint loading (e.g. stair walking or squatting) and rarely they 319 
report pain at rest (35). Patients with knee OA often report pain at rest and also 320 
during walking. Collectively the lack of facilitating temporal summation may suggest 321 
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that long pain duration is not the only factor, which is required to cause changes in 322 
temporal summation. 323 
 324 
Conditioned pain modulation 325 
Young female adults with PFP had a less efficient CPM similar to what have been 326 
observed in older adults with knee OA (31). Less-efficient CPM mechanisms have 327 
previously been reported in patients with musculoskeletal pain conditions, such as 328 
myofascial temporomandibular disorders (36), chronic low back pain (37), and 329 
fibromyalgia (38) but this study is the first to report impaired CPM in a younger 330 
patient population. A reduced potency of the descending control makes the entire 331 
neuroaxis more vulnerable to pain (39). However, an important finding is that the 332 
CPM response was highly variable among the young female adults with PFP. Some 333 
had no change in PDT during the test stimulus while others had responses similar to 334 
pain-free controls. Earlier studies have linked a less efficient CPM response to 335 
poorer long-term outcome after thoracotomy (17). Although pure speculation, this 336 
may also be the case for young female adults with PFP who are known for having a 337 
high degree of chronicity with only 1/3 being pain-free one year after treatment (40, 338 
41). Eleven pain-free controls reached maximum in their pain tolerance threshold 339 
assessment before the conditioning stimulus was applied which made it impossible 340 
to compare the effect of the conditioning stimulus on their pain tolerance threshold. 341 
 342 
CPM and temporal summation of pain are both considered part of central pain 343 
processing but reflect two different mechanisms. Conditioned pain modulation 344 
originates from the activation of brainstem inhibitory projections that, in turn, act to 345 
postsynaptically inhibit spinal and trigeminal wide dynamic-range neurons (42). The 346 
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inability of the noxious conditioning stimulus to increase pain thresholds indicates a 347 
potential deficiency in the body’s endogenous pain modulatory ability. Temporal 348 
summation is thought to be a facilitating mechanism that mimics the initial phase of 349 
the windup process in dorsal horn neurons seen in animals (43). Therefore, the data 350 
from this study suggests that mainly the inhibitory mechanism is affected in young 351 
female adults with PFP. 352 
 353 
Pressure and cuff pain sensitivity 354 
Young adults with PFP had lower PPTs but showed no difference in either PDT or 355 
PTT measured with the cuff algometer. The reason might be that cuff algometry 356 
primarily captures deep tissue hyperalgesia while mechanical PPTs measure 357 
hyperalgesia of superficial structures and muscles (8, 44). Reduced efficiency of the 358 
CPM system may explain the widespread hyperalgesia. However, the present 359 
population may have a lower degree of central sensitization compared to patients 360 
with knee OA who are often characterised by facilitated temporal summation, 361 
widespread hyperalgesia, and an inefficient CPM system (10). An important aspect 362 
when interpreting these results is that this population is much younger than previous 363 
studies on older adults with chronic pain. Although not heavily researched it appears 364 
that changes in pain processing is dependent on the age of the individual (45). 365 
Emerging evidence suggests that there might be some critical periods during 366 
adolescence and childhood where pain experiences might induce long-lasting and 367 
specific effects not observed among adults (45). However, it does appear that PPTs 368 
may change in response to recovery. A recent study demonstrated that adolescents 369 
with PFP deeming themselves as recovered after 3 months of exercise therapy had 370 
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a 68-76 kPa larger improvement in PPTs around the knee and tibialis anterior 371 
compared to adolescents with not recovered after treatment (46).   372 
 373 
Strengths and limitations 374 
A strength of the study is that all the participants were recruited from a large, well-375 
defined, population-based cohort that have been followed for three years. 376 
Recruitment of a population-based sample suggests that our data may be 377 
generalizable to young female adults with long-standing PFP. An examiner blinded 378 
to group allocation was used to minimise the risk of detection bias which is a 379 
significant strength.  380 
The present findings may not apply to the male population of young adults with PFP, 381 
as only females were included. The results may only apply to female adults with PFP 382 
who developed knee pain during their early teens and not those who develop knee 383 
pain during adulthood. Hormonal status of the participants was not assessed which 384 
may introduce an unsystematic bias and reduce the difference in pain sensitivity 385 
between groups. No reliability studies have been performed among this population 386 
and no data exist for the minimally clinically important change. This makes it difficult 387 
to interpret the relative difference between groups.  388 
 389 
Clinical implications 390 
Based on the large variation in CPM response among the young female adults with 391 
PFP it seems likely that altered central processing of pain is only present within a 392 
subgroup. It is known from a previous randomised trial among adolescents with PFP 393 
that there is a subgroup of adolescents who does not respond favourably to the 394 
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current best available evidence-based treatment, exercise therapy (23). It may be 395 
that this subgroup is characterised by facilitated central mechanisms and treatment 396 
among this subgroup should move away from the mechanical paradigm focusing 397 
purely on improving strength and restoring lower extremity alignment. Instead 398 
normalisation of the hyperexcitability of the nervous system should be targeted. 399 
Interestingly, exercise-induced hypoalgesia may be affecting the facilitated central 400 
mechanisms in the subgroup with efficient exercise therapy (47).  401 
 402 
This study demonstrated that young female adults with long-standing patellofemoral 403 
pain were characterized by impaired conditioned pain modulation. This is the first 404 
study to provide evidence of an altered pain processing among young female adults 405 
with patellofemoral pain which is important as patellofemoral pain might have an 406 
important pain processing component which needs to be studied in order to 407 
understand its extent and therapeutic implications. 408 
 409 
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